Coronary/Structural Heart

INVOKANA® (canagliflozin) Significantly Reduces the Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease

ORLANDO, Fla., March 11, 2018 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new analysis showing that INVOKANA® (canagliflozin) significantly reduced the risk of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) at high CV risk. This exploratory […]

Infraredx Highlights Value of IVUS + NIRS for Detecting Lipid Core Plaque at the American College of Cardiology 67th Annual Scientific Session

BURLINGTON, Mass.–(BUSINESS WIRE)– InfraReDx, Inc., a pioneer in intravascular imaging for mapping coronary artery disease, today presented a poster at the American College of Cardiology (ACC) 67th Annual Scientific Session supporting the value of combination intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) imaging technology to identify lipid core plaque (LCP), an underlying cause of serious […]

Clinical trial finds Philips’ instant wave-free ratio (iFR) more cost-effective than fractional flow reserve (FFR) in the guidance of percutaneous coronary intervention (PCI) for heart disease

AMSTERDAM and ORLANDO, Florida, March 10, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced health economic results from the DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the guidance of treatment of ischemic heart […]

Clinical Trials Show Strong Long-Term Performance with the Medtronic CoreValve TAVR System

Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time DUBLIN and ORLANDO – March 10, 2018 – Medtronic plc (NYSE: MDT) today unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic Aortic […]

Lantheus Presents New Data on Novel Cardiac PET Imaging Agent LMI 1195 in Development for the Diagnostic Assessment of Ischemic Heart Failure Patients at Risk for Sudden Cardiac Death at ACC.18

NORTH BILLERICA, Mass.–(BUSINESS WIRE)–Lantheus Holdings, Inc. (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents, today announced positive new data from a Phase 2 study of LMI 1195, a fluorine-18 (F18) labeled tracer for […]

From Planning to Post-Op, Canon Medical Systems Delivers a Complete Suite of Structural Heart Imaging Solutions

TUSTIN, Calif.–(BUSINESS WIRE)–From accurate, precise planning to successful implementation of aortic and mitral valve replacements and post-operative evaluation, Canon Medical Systems USA, Inc. delivers a complete suite of imaging solutions for structural heart interventions. Features such as the Volumetric Scan Mode on the Aquilion™ ONE / GENESIS Edition, which enables the heart […]

SentreHEART Announces Participation at The American College of Cardiology’s 67th Annual Scientific Session & Expo

REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the American College of Cardiology (ACC) 2018 meeting being held in Orlando, Florida, March 10-12, 2018. The meeting’s agenda includes several sessions dedicated to exploring device-based options for Left Atrial Appendage (LAA) […]

At ACC, Siemens Healthineers Introduces a Portable Cardiovascular-Dedicated Ultrasound System

ORLANDO, Fla.–(BUSINESS WIRE)– ACC 2018: Booth #3127— At the American College of Cardiology’s 67th Annual Scientific Session and Expo, Siemens Healthineers launched its new portable cardiovascular ultrasound solution, the ACUSON Bonsai. According to a recent study, 34 million echo exams were performed in the U.S. in 2017.1 The ACUSON Bonsai addresses the challenge of these […]

Marketwired: Mar 08, 2018 — Novoheart’s Landmark, Peer-Reviewed Study Published, Recognizing the Effectiveness of the World’s First and Only Human Heart-in-a-Jar

VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Mar 08, 2018 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH)(FRANKFURT: 3NH) is pleased to announce that it has published a comprehensive study of the world’s first human heart-in-a-jar, in the prestigious bioengineering journal Biomaterials. The peer-reviewed paper showcases the human heart-in-a-jar’s unique ability to recapitulate […]

Saranas’ Novel Bleed Monitoring System Receives Recognition in Cardiovascular Research Technologies 2018 Competition

HOUSTON–(BUSINESS WIRE)– Saranas, a medical device company with a cutting-edge technology for real-time detection and monitoring of internal bleeding during endovascular procedures, placed first runner-up at the Cardiovascular Research Technologies (CRT) competition on March 6, 2018, in Washington, D.C. “We are extremely honored that our Early Bird™ Bleed Monitoring System has been recognized […]